Cargando…

Hypertension and Diabetes in Obesity

Detalles Bibliográficos
Autores principales:	Masuo, Kazuko, Tuck, Michael L., Lambert, Gavin W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124686/ https://www.ncbi.nlm.nih.gov/pubmed/21747982 http://dx.doi.org/10.4061/2011/695869

Ejemplares similares

Relationships of Adrenoceptor Polymorphisms with Obesity
por: Masuo, Kazuko, et al.
Publicado: (2011)

Roles of Beta2- and Beta3-Adrenoceptor Polymorphisms in Hypertension and Metabolic Syndrome
por: Masuo, Kazuko
Publicado: (2010)

Oxidative Stress and Inflammation in Obesity, Diabetes, Hypertension, and Related Cardiometabolic Complications
por: Ndisang, Joseph Fomusi, et al.
Publicado: (2014)

Weight Loss May Reverse Blunted Sympathetic Neural Responsiveness to Glucose Ingestion in Obese Subjects With Metabolic Syndrome
por: Straznicky, Nora E., et al.
Publicado: (2009)

Obesity‐Induced Hypertension: Heavy on the Accelerator
por: Roush, George C.
Publicado: (2019)

Sleep Disorders, Obesity, Hypertension, and Cardiovascular Risk
por: McFarlane, Samy I., et al.
Publicado: (2015)

Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects
por: Straznicky, Nora E., et al.
Publicado: (2010)

Does the Epigenome Hold Clues to Leptin-associated Hypertension in Obesity?
por: Lingappan, Krithika
Publicado: (2021)

Intergenerational diabetes and obesity—A cycle to break?
por: Ma, Ronald C. W., et al.
Publicado: (2017)

Next Steps: Eliminating Disparities in Diabetes and Obesity
por: Haire-Joshu, Debra L.
Publicado: (2015)

Autonomic Neuropathy in Diabetes Mellitus and Obesity: An Update
por: Katsilambros, Nicholas L., et al.
Publicado: (2011)

Oxidative stress: link between hypertension and diabetes
por: Moon, Jun Sung, et al.
Publicado: (2017)

Increasing Role of Overweight/Obesity as the Determinant of Hypertension and the Consequent Cardiovascular Diseases in Japan
por: Yatsuya, Hiroshi
Publicado: (2023)

Obesity and diabetic retinopathy: What is the association?
por: Heidari, Behzad
Publicado: (2015)

Advent of tirzepatide: boon for diabetic and obese?
por: Bhusal, Amrit
Publicado: (2023)

Obesity, Insulin Resistance, and Asthma
por: Allinson, James P., et al.
Publicado: (2022)

Response to Comment on: Straznicky et al. Neuroadrenergic Dysfunction Along the Diabetes Continuum: A Comparative Study in Obese Metabolic Syndrome Subjects. Diabetes 2012;61:2506–2516
por: Straznicky, Nora E., et al.
Publicado: (2013)

Impact of Maternal Obesity and Diabetes on Long-Term Health of the Offspring
por: Maric-Bilkan, Christine, et al.
Publicado: (2011)

Prevalence, Awareness, and Control of Hypertension among Diabetic Koreans
por: Chung, Hyun Hee, et al.
Publicado: (2011)

Genomics and Metabolomics in Obesity and Type 2 Diabetes
por: Kretowski, Adam, et al.
Publicado: (2016)

Biomarker-based Inflammatory Score in Obese Patients with Resistant Hypertension
por: Rodrigues, Cibele Isaac Saad
Publicado: (2019)

New DH-BSC Recommendations on Optimal Management of Hypertension in Diabetics
por: Coca, Antonio
Publicado: (2013)

Microvascular benefits of hypertension and glucose control in type 2 diabetes
por: Van Rensburg, BWJ
Publicado: (2008)

Inflammation and Oxidative Stress in Obesity, Metabolic Syndrome, and Diabetes
por: Galassetti, Pietro
Publicado: (2012)

The Effects of Green Tea on Obesity and Type 2 Diabetes
por: Kim, Hyun Min, et al.
Publicado: (2013)

New risk factors for obesity and diabetes: Environmental chemicals
por: Jeon, Ja Young, et al.
Publicado: (2015)

GLP-1 Based Combination Therapy for Obesity and Diabetes
por: Lee, Young Hee, et al.
Publicado: (2017)

Tenascin-C: an emerging prognostic biomarker in diabetes
por: Yonebayashi, Saori, et al.
Publicado: (2020)

Hypertension Management: Ripe for Disruption
por: Hess, Paul L., et al.
Publicado: (2016)

Hypertension and Diabetes: Entry Points for Prevention and Control of the Global Cardiovascular Epidemic
por: Mendis, Shanthi, et al.
Publicado: (2013)

Hypertension and diabetes mellitus in patients with COVID 19: a viewpoint on mortality
por: Tascioglu, Didem, et al.
Publicado: (2020)

Medicinal Plants and Natural Active Compounds for Diabetes and/or Obesity Treatment
por: Zaid, Hilal, et al.
Publicado: (2015)

Role of Tissue and Systemic Hypoxia in Obesity and Type 2 Diabetes
por: Xi, Lei, et al.
Publicado: (2016)

Magnesium in Type 2 Diabetes Mellitus, Obesity, and Metabolic Syndrome
por: Barbagallo, Mario, et al.
Publicado: (2022)

Heart Rate Variability in Coexisting Diabetes and Hypertension
por: Martinez, Paula F., et al.
Publicado: (2018)

Hypertension in Asia 2021: A major contribution to worldwide understanding and management of hypertension
por: Weber, Michael A., et al.
Publicado: (2021)

Advancing health system strengthening through improving access to medicines: A review of local manufacturing policies in Ghana
por: Peprah Boaitey, Kwame, et al.
Publicado: (2020)

Natural Products for the Treatment of Obesity, Metabolic Syndrome, and Type 2 Diabetes
por: Thounaojam, Menaka C., et al.
Publicado: (2013)

Lifestyle Modification Strategies to Counteract the World Epidemic Growth of Obesity and Diabetes
por: De Feo, Pierpaolo, et al.
Publicado: (2014)

mHealth and eHealth for Obesity and Types 2 and 1 Diabetes
por: Castelnuovo, Gianluca, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u4916cr779i3j310dtr7a4vlj4